Nasdaq agrx.

The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”Find the latest Insider Activity data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.Jun 27, 2017 · AGRX tried to move up and failed, broke the support level yesterday, and is now trading below it. Our idea is to take AGRX if it breaks the $ 1.97 price for further dec Hi traders, The consumer sector has been in a sharp decline in recent days and we have a trading idea in AGRX for further declines. AGRX tried to move up and failed, broke the ... The Company’s common stock will open for trading on the Nasdaq Market on Wednesday, April 27, 2022 on a split-adjusted basis under the current trading symbol "AGRX."

PRINCETON, N.J., Oct. 07, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has reorganized and streamlined its executive ...A. The latest price target for Agile Therapeutics ( NASDAQ: AGRX) was reported by Maxim Group on Friday, September 22, 2023. The analyst firm set a price …... Nasdaq Listing Rule 5635(c)(4). GlobeNewswire Oct 4, 2023 1:30pm. Agile Therapeutics (NASDAQ: AGRX) Upgraded To “Buy” Rating By Analysts At Maxim Group.

AGRX U.S.: Nasdaq Agile Therapeutics Inc. Watch list NEW Set a price target alert Open Last Updated: Nov 15, 2023 10:21 a.m. EST Real time quote $ 2.2182 0.3182 16.75% Previous Close $1.9000...PRINCETON, N.J., March 31, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the launch of its first consumer commercial intended to ...

The Nasdaq Stock Market requires companies to maintain a minimum share price of $1. And yet 464 companies listed on the exchange were trading for less than $1 …PRINCETON, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months ended March 31, 2022 ...PRINCETON, N.J., April 22, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that the company has nominated Sharon ...Agile Therapeutics (AGRX – Research Report) received a Hold rating and price target from Maxim Group analyst Naz Rahman yesterday. The c... Agile Therapeutics (AGRX – Research Report) received a Hold rating and price target from Max...Dec 1, 2023 · Agile Therapeutics, Inc. (NASDAQ:AGRX) announced its earnings results on Tuesday, November, 2nd. The specialty pharmaceutical company reported ($7.20) EPS for the quarter, beating analysts' consensus estimates of ($7.60) by $0.40. The specialty pharmaceutical company earned $1.29 million during the quarter, compared to analysts' expectations of ...

Dec 1, 2023 · According to the issued ratings of 2 analysts in the last year, the consensus rating for Agile Therapeutics stock is Buy based on the current 2 buy ratings for AGRX. The average twelve-month price prediction for Agile Therapeutics is $8.50 with a high price target of $12.00 and a low price target of $5.00. Learn more on AGRX's analyst rating ...

Apr 26, 2022 · The Company’s common stock will open for trading on the Nasdaq Market on Wednesday, April 27, 2022 on a split-adjusted basis under the current trading symbol "AGRX."

The Company’s common stock will open for trading on the Nasdaq Market on Wednesday, April 27, 2022 on a split-adjusted basis under the current trading symbol "AGRX."The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”Le cours de l'action AGILE THERAPEUT AGRX sur Boursorama : historique de la cotation sur NASDAQ, graphique, actualités, consensus des analystes et ...Agile Therapeutics Stock (NASDAQ:AGRX), Quotes and News Summary · Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of ...PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three months ended June 30 ...15 Jun 2023 ... Agile's Capital Raise Strategies In A Competitive Market: NASDAQ: $AGRX CEO Al Altomari's Approach. 80 views · 2 months ago #WomensHealth #AGRXAgile Therapeutics, Inc. (NASDAQ: AGRX) (after the close) Tuesday . Boston Scientific Corporation (NYSE: BSX) (before the market open) Masimo Corporation (NASDAQ: MASI) (after the close)

PRINCETON, N.J., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's healthcare company, today reported financial results for the three and nine months ended ...现金流量表 · 分红派息. 相关信息. 公司简介 · 高管 · 董事会 · 中国概念股. AGRX NASDAQ:AGRX Agile Therapeutics,. 添加自选 在APP中查看. 普通版 极速版. 盘后：. @ ...PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile” or the “Company”), a women's healthcare company, today announced that it has received written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) granting the Company’s request for a 180 …AGRX earnings call for the period ending June 30, 2022. Image source: The Motley Fool. Agile Therapeutics ( AGRX 1.60%) Q2 2022 Earnings Call. Aug 11, 2022, 4:30 p.m. ET.Agile Therapeutics, Inc. Common Stock (AGRX) Historical Closing Prices - View free historical Nasdaq official closing price data at Nasdaq.com.PRINCETON, N.J., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's healthcare company, today reported financial results for the three and nine months ended ...

The Nasdaq is up 3,719.01 points, or 35.5%. The Russell 2000 is up 120.77 points, or 6.9%. The Associated Press is an independent global news organization …

Agile Therapeutics, Inc. (Agile or the Company) (NasdaqCM: NASDAQ: AGRX) is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Agile ...PRINCETON, N.J., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months ended June 30, 2022 ...Nasdaq News: This is the News-site for the company Nasdaq on Markets Insider Indices Commodities Currencies StocksStock analysis for Agile Therapeutics Inc (AGRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.PRINCETON, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that it intends to offer and sell shares of its common ...15 Jun 2023 ... Agile's Capital Raise Strategies In A Competitive Market: NASDAQ: $AGRX CEO Al Altomari's Approach. 80 views · 2 months ago #WomensHealth #AGRX

PRINCETON, N.J., July 06, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the closing of its ...

The technology sector, broadly speaking, is having a great year. The Nasdaq-100 tech index has jumped 47% so far, and it's now a stone's throw away from …

... Therapeutics Inc (AGRX). Agile Therapeutics Inc (AGRX). 2.16 +0.05 (+2.37%) 12/01/23 [NASDAQ]. N/A x N/A N/A x N/A. Realtime by (Cboe BZX). N/A x N/A N/A x N/A.EQS-News: Agile Therapeutics, Inc. NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022 21.10.2022 / 17:00 CET/CEST The issuer is solely responsible for the...Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58.Agile Therapeutics (NASDAQ:AGRX – Get Free Report) last released its quarterly earnings results on Thursday, November 9th. The specialty pharmaceutical company reported ($1.47) EPS for the quarter.PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its ...PRINCETON, N.J., Dec. 01, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company announced today that it has received net proceeds of ...Nasdaq Futures. 15,953.25 ... (NASDAQ:AGRX) to a "buy" rating. Agile Therapeutics is a women's healthcare company that is "dedicated to fulfilling the unmet needs of today's women." Its product ...PRINCETON, N.J., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced a partnership with Pandia Health, an online telehealth ...

View real-time AGRX stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ... The principal risks of investing in the Fund are: Market Risk. The market values of the Fund’s investments, and therefore the value of the Fund’s shares, will go up and down, sometimes rapidly or unpredictably. Market risk may affect a single issuer, industry or section of the economy, or it may affect the market as a whole.Stock analysis for Agile Therapeutics Inc (AGRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Agile Therapeutics (NASDAQ:AGRX – Get Free Report) last released its quarterly earnings results on Thursday, November 9th. The specialty pharmaceutical company reported ($1.47) EPS for the quarter.Instagram:https://instagram. canopy stocksthe new economy fundge stock buy or sellai c3 See the latest Agile Therapeutics Inc stock price (AGRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. data storage corporationishares select dividend etf Nasdaq +78.81(+0.55%) Russell 2000 1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Agile Therapeutics, Inc. (AGRX) NasdaqCM - NasdaqCM Real... Find the latest Earnings Report Date for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com. nyse lode Insider Monkey Transcripts. Agile Therapeutics, Inc. (NASDAQ: AGRX) Q3 2023 Earnings Call Transcript November 9, 2023. Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58. Operator: Good morning, and welcome to the Agile Therapeutics Third Quarter 2023 Financial Results Conference Call.Agile Therapeutics Inc (NASDAQ:AGRX) Agile Therapeutics Inc. 1.90. Delayed Data. As of Nov 14. -0.02 / -1.04%. Today’s Change. 1.65. Today ||| 52-Week Range.